The future of cancer treatment – combining stem cells and immunotherapy.
The company leads a Department of Industry, Innovation and Science Co-operative Research Centre project in partnership with the Hudson Institute of Medical Research, Monash University, Mesoblast Ltd and Cell Therapies Pty Ltd.
Cartherics is:
- Creating a new class of cancer treatments beyond surgery, chemotherapy, biologicals and radiation.
- Supercharging a patient’s own immune system, helping it eliminate cancer.
- Developing accessible ‘off-the-shelf’ immunotherapies to fight aggressive forms of cancers like relapsed ovarian and gastric cancers.
Transforming cancer from a fatal disease to a manageable condition.
Cell Therapy News/Articles, page-8332
-
- There are more pages in this discussion • 9,914 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |